Irritable Bowel Syndrome is real, and it is extremely common, affecting roughly 5% of Americans, or one in 20.

“Irritable bowel syndrome does not increase your risk of colon cancer,” says David Palange, DO, a colon and rectal surgeon at ChristianaCare’s Helen F. Graham Cancer Center and Research ...

The current treatment of irritable bowel syndrome (IBS) is still problematic. Several agents that were introduced in the past had side effects that led to their removal from the market.

Meals that are too large can over-stimulate the bowel, which may cause cramping and diarrhoea. Every person with IBS varies, but spices, wheat, milk and foods with irritating skins and seeds ...

Richard Lea, MD, Clinical Research Fellow, Medical Academic Department, South Manchester University Hospitals, Manchester, United Kingdom Peter J. Whorwell, MD, Professor of Medicine and ...

Approximately two-thirds of patients with Crohn's disease who initially responded to tumor necrosis factor (TNF) inhibitors ...

Despite the publication of NICE Clinical Guideline 61 (CG61) in 2008 aiming for appropriate management of irritable bowel syndrome (IBS) within primary care, its recommendations were not being ...

TC Energy Corporation engages in the provision of energy infrastructure services. It operates through the following business segments: Canadian Natural Gas Pipelines, U.S. Natural Gas Pipelines ...

U.S. Physical Therapy, Inc. operates outpatient physical ... and neurological-related injuries. The company also operates two clinics which specialize in the outpatient and non-surgical treatment ...

Feb. 8, 2023 — Researchers have found differences in the gut microbiomes of people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) compared to healthy controls. Findings from ...

Jan. 24, 2024 — Researchers have identified a gene that causes heart defects in Down syndrome, a condition that results from an additional copy of chromosome 21. Reducing the overactivity of ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...